JMIRx Med - Vol 1, No 1 (2020): Jan-Dec

#xPublicandGlobalHealth

View E-collection for ‘#xPublicandGlobalHealth’

View image

No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19

Moshe Rogosnitzky, Esther Berkowitz, Alejandro R Jadad

JMIRx Med 2020 (Sep 30); 1(1):e19583

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study

Eric Luellen

JMIRx Med 2020 (Oct 19); 1(1):e23582

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study

Tara Fusillo

JMIRx Med 2020 (Dec 02); 1(1):e22470

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

Peer Reviews

View E-collection for ‘Peer Reviews’

View image

Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”

Ahmed Abdeen Hamed

JMIRx Med 2020 (Sep 30); 1(1):e24453

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”

Susan Howlett

JMIRx Med 2020 (Sep 30); 1(1):e24481

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”

Andy Chang

JMIRx Med 2020 (Oct 19); 1(1):e24747

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”

Eric Abbott

JMIRx Med 2020 (Oct 19); 1(1):e24765

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”

Ross Gore

JMIRx Med 2020 (Dec 02); 1(1):e25572

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

Authors' Responses to Peer-Reviews

View E-collection for ‘Authors' Responses to Peer-Reviews’

View image

Authors’ Response to Peer Reviews of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”

Moshe Rogosnitzky, Esther Berkowitz, Alejandro R Jadad

JMIRx Med 2020 (Sep 30); 1(1):e24485

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

Author Response to Peer Reviews of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”

Eric Luellen

JMIRx Med 2020 (Oct 19); 1(1):e24739

Download Citation: END BibTex RIS

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn

Download PDF Download XML

View image

Author’s Response to Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”